
SII applies for full market authorisation of Covishield as supplies of vaccine exceeded 125 crore doses
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government
Published: 31st December 2021 03:10 PM | Last Updated: 31st December 2021 03:18 PM | A+A A-